Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
DTS INC DTSI
6.89%
ANIKA THERAP ANIK
6.04%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%

GAO Confirms UNH TRICARE W. Award

by Zacks Equity Research

July 05, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

The Government Accountability Office (GAO) confirmed the U.S. Department of Defense’s (DoD) TRICARE Managed Care Support contract award to UnitedHealth Group Inc. (UNH - Analyst Report). This TRICARE contract for the West region would be effective from April 2013. Under this administrative services contract, the company will support health care delivery to approximately 2.9 million eligible beneficiaries who are active duty service members, retirees and family members based in 21 states of TRICARE’s West region. The contract consists of five one-year option periods and is valued at $20.5 billion.

TRICARE is a health insurance service program meant for working as well as retired military service members and their families.

The TRICARE west region was served by TriWest Healthcare Alliance Corp. since 1996, and was currently serving the area as per the 2003 contract. UnitedHealth raised its doubts over the contract in 2009 and managed to persuade the Department to reconsider its decision. The Department discovered the errors made in the west region contract award and finally reversed its decision in UnitedHealth’s favor.

The contract gives UnitedHealth, the largest U.S. health insurer (on the basis of revenue), access to the military health care market, an area in which the company has sought to establish its presence for quite some time. Last year, the company also sued the DoD for the TRICARE southern region contract valued at $23.5 billion, but lost the contract to Humana Inc. (HUM - Analyst Report).

The contract will accrue considerably to UnitedHealth’s top line, which posted consolidated revenues of $102 billion in 2011. However, the loss of the TRICARE contract will erase much of the total revenue from TriWest as the military business forms the main component of the company’s business.

It is also expanding geographically to offset the restrictions imposed by the Health Care Reform back home. The company is also developing its health service business, branded as Optum, and has made a number of acquisitions recently in this regard.

UnitedHealth is uniquely poised to gain from the changing landscape in the health insurance industry. The company has made a number of acquisitions, both big and small, to reshape its business in the face of new Health Care Reform regulations.

UnitedHealth currently retains a Zacks #3 Rank, which translates into a short-term ‘Hold’ rating. We are also maintaining our long-term “Neutral” recommendation on its shares.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.